FDA’s Sequestered User Fees From FY 2013 Likely Gone, But FY 2014 Fees Could Be Exempted
This article was originally published in The Pink Sheet Daily
Executive Summary
Rep. Farr says Congressional Budget Office scoring problems could not be overcome, meaning FY 2013 FDA user fees lost to sequester may not be recovered, but amendment will be proposed to ensure FY 2014 fees are not lost in the upcoming appropriations bill.
You may also be interested in...
FDA Strains Under New NDA Review Model; Will Industry Want To Retain It?
Scheduling mid- and late-cycle meetings complicates reviews for FDA, but the fate of the “Program” probably depends on whether industry feels the extra two months produces better outcomes.
FDA Mandates Need Accompanying Resources, Hamburg Says
The mandates in the FDA Safety and Innovation Act and Drug Quality and Security Act show a lot of congressional confidence in the agency, but FDA commissioner says that members also must provide resources to go with it.
Hamburg, Like Industry, Wants Predictability – But In FDA Funding
Commissioner says the agency cannot operate effectively without predictable budgets and that sequestered user fees are needed now.